Attend virtual education event for gynecologic cancer care

March 24, 2022 Providence Cancer Institute of Oregon

Join Andrea Hardy, RN, BSN, Providence gynecologic oncology nurse care coordinator, on March 9 for Coping with Chemotherapy. This is a free, virtual educational event for gynecologic cancer patients and their caregivers presented by the Ovarian Cancer Alliance of Oregon & SW Washington in collaboration with Providence Cancer Institute of Oregon.

Andrea will help empower patients to take an active role in their own health care by helping them understand chemotherapy and its side effects, both physically and emotionally.

Topics will include:

Taking an active role in your care
Understanding chemotherapy
Most common types of chemotherapy, including immunotherapy and oral PARP inhibitors
Understanding and managing the side effects of chemotherapy
Communicating with your health care team

Event details

Wednesday, March 9, 2022

5:00 p.m. - 6:15 p.m. PT

Register here

About the presenter

Andrea Hardy, RN, BSN, is a Gynecologic Oncology Nurse Care Coordinator at Providence Cancer Institute of Oregon. She cares for patients with gynecologic cancer throughout their diagnosis, treatment, and survivorship. Among her various nursing services, Andrea provides patient education for symptom management over the course of treatments, starting with chemotherapy. This support helps to ease the journey into the unknown and empowers patients to participate in their own health care.

About the Providence Gynecologic Oncology Program

The Providence Gynecologic Cancer Program provides highly specialized care for patients diagnosed with ovarian, cervical, uterine, vaginal, vulvar and other female reproductive tract cancers, as well as pre-cancerous conditions. Patients receive advanced treatments, from robotic surgery to immunotherapy, with the opportunity to participate in clinical trials. To learn more, visit ProvidenceOregon.org/gyncancer.

Related resources

Gynecologic oncology care now available at Providence Cancer Institute

Clinical trial aims to help premenopausal women at risk for ovarian cancer

Phase II study of neoadjuvant combination therapy for ovarian cancer

Welcome to your journey for creating a healthier you

Attend virtual education event for gynecologic cancer care

Previous Article

Next Article

Attend virtual education event for gynecologic cancer care

Previous Article

Next Article

Other content in this Stream

New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

Providence Cancer Institute in partnership with AIM at Melanoma present a free online event designed to educate and empower patients and care partners affected by melanoma.

The awards highlight Providence Swedish's consistency in following the American Heart Association's guidelines for care, treatment and improved outcomes in stroke and diabetes.

Menopause is a natural aging process for roughly half the population. Learn how to navigate the journey from perimenopause to menopause and beyond.

What motivates the co-captains of the FINISHCANCER caregiver team to commit their time to running this remarkable relay? Read what they say about preparing for the race and what inspires them to run.

Providence Community Cancer Screening Event

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Providence Cancer Institute presented a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

Sprawling multi-million dollar facility in Orange County is a one-stop location to access full-suite of women’s health, mother-baby services and more

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

At Providence, we recognize the importance of providing holistic care and comprehensive prenatal, labor and delivery, and postpartum support for Black birthing parents and babies.

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Learn the truth about endometriosis, including the symptoms, treatments and more in this comprehensive guide from Providence.